Cargando…

The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis

Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Biqian, Xi, Shengyan, Wang, Yanhui, Zhai, Xiangyang, Wang, Yanan, Gong, Yuewen, Xu, Yangxinzi, Yang, Jiaqi, Qiu, Yingkun, Wang, Jing, Lu, Dawei, Huang, Shuqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331466/
https://www.ncbi.nlm.nih.gov/pubmed/30670974
http://dx.doi.org/10.3389/fphar.2018.01539
_version_ 1783387137137180672
author Fu, Biqian
Xi, Shengyan
Wang, Yanhui
Zhai, Xiangyang
Wang, Yanan
Gong, Yuewen
Xu, Yangxinzi
Yang, Jiaqi
Qiu, Yingkun
Wang, Jing
Lu, Dawei
Huang, Shuqiong
author_facet Fu, Biqian
Xi, Shengyan
Wang, Yanhui
Zhai, Xiangyang
Wang, Yanan
Gong, Yuewen
Xu, Yangxinzi
Yang, Jiaqi
Qiu, Yingkun
Wang, Jing
Lu, Dawei
Huang, Shuqiong
author_sort Fu, Biqian
collection PubMed
description Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H(22) hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H(22) HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G(0)-G(1) transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy.
format Online
Article
Text
id pubmed-6331466
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63314662019-01-22 The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis Fu, Biqian Xi, Shengyan Wang, Yanhui Zhai, Xiangyang Wang, Yanan Gong, Yuewen Xu, Yangxinzi Yang, Jiaqi Qiu, Yingkun Wang, Jing Lu, Dawei Huang, Shuqiong Front Pharmacol Pharmacology Ciji-Hua’ai-Baosheng II Formula (CHB-II-F) is a traditional Chinese medical formula that has been shown in clinical practice to relieve side effects of chemotherapy and improve quality of life for cancer patients. In order to understand the mechanism of its protective effects on chemotherapy, mice with transplanted H(22) hepatocellular carcinoma were employed in this study. Ninety-two mice were injected subcutaneously with H(22) HCC cell suspension into the right anterior armpit. After mice were treated with 5-fluorine pyrimidine (5-FU), they were divided into six groups as untreated group, 5-FU group, 5-FU plus Yangzheng Xiaoji Capsule group and three groups of 5-FU plus different concentrations of CHB-II-F. Twenty mice were euthanized after 7 days of treatment in untreated and medium concentration of CHB-II-F groups and all other mice were euthanized after 14 days of treatment. Herbal components/metabolites were analyzed by UPLC-MS. Tumors were evaluated by weight and volume, morphology of light and electron microscope, and cell cycle. Apoptosis were examined by apoptotic proteins expression by western blot. Four major components/metabolites were identified from serum of mice treated with CHB-II-F and they are β-Sitosterol, Salvianolic acid, isobavachalcone, and bakuchiol. Treatment of CHB-II-F significantly increased body weights of mice and decreased tumor volume compared to untreated group. Moreover, CHB-II-F treatment increased tumor cells in G(0)-G(1) transition instead of in S phase. Furthermore, CHB-II-F treatment increased the expression of pro-apoptotic proteins and decreased the expression anti-apoptotic protein. Therefore, CHB-II-F could improve mice general condition and reduce tumor cell malignancy. Moreover, CHB-II-F regulates apoptosis of tumor cells, which could contribute its protective effect on chemotherapy. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331466/ /pubmed/30670974 http://dx.doi.org/10.3389/fphar.2018.01539 Text en Copyright © 2019 Fu, Xi, Wang, Zhai, Wang, Gong, Xu, Yang, Qiu, Wang, Lu and Huang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fu, Biqian
Xi, Shengyan
Wang, Yanhui
Zhai, Xiangyang
Wang, Yanan
Gong, Yuewen
Xu, Yangxinzi
Yang, Jiaqi
Qiu, Yingkun
Wang, Jing
Lu, Dawei
Huang, Shuqiong
The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
title The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
title_full The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
title_fullStr The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
title_full_unstemmed The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
title_short The Protective Effects of Ciji-Hua’ai-Baosheng II Formula on Chemotherapy-Treated H(22) Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis
title_sort protective effects of ciji-hua’ai-baosheng ii formula on chemotherapy-treated h(22) hepatocellular carcinoma mouse model by promoting tumor apoptosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331466/
https://www.ncbi.nlm.nih.gov/pubmed/30670974
http://dx.doi.org/10.3389/fphar.2018.01539
work_keys_str_mv AT fubiqian theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT xishengyan theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT wangyanhui theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT zhaixiangyang theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT wangyanan theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT gongyuewen theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT xuyangxinzi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT yangjiaqi theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT qiuyingkun theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT wangjing theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT ludawei theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT huangshuqiong theprotectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT fubiqian protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT xishengyan protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT wangyanhui protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT zhaixiangyang protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT wangyanan protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT gongyuewen protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT xuyangxinzi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT yangjiaqi protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT qiuyingkun protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT wangjing protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT ludawei protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis
AT huangshuqiong protectiveeffectsofcijihuaaibaoshengiiformulaonchemotherapytreatedh22hepatocellularcarcinomamousemodelbypromotingtumorapoptosis